Territorial Availability: Available through Bertin Technologies only in France
- Synonyms
- 6-[2-[4-[(4-fluorophenyl)phenylmethylene]-1-piperidinyl]ethyl]-7-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one
- Correlated keywords
- 93076-98-3 biochemical inhibitor kinase cancer intracellular signaling diacylglycerol DAG-dependent DKG inhibit R59022 PKC activity aggregation thrombin-stimulated platelet block vascular contraction thromboxane TX analog U-46619 U46619 apoptosis programmed cell death glioblastoma DGK-? in vitro vivo Arabidopsis thaliana DGK2 suppress root growth DKGI-I DKGII
- Product Overview:
Diacylglycerol (DAG) kinases (DGKs) phosphorylate DAG to give phosphatidic acid (PA), reducing signaling through DAG and increasing signaling through PA.{7274} R-59-022 is an inhibitor of DGK (IC50 = 2.8 µM).{27715} This results in increased DAG-dependent PKC activity and potentiates aggregation of thrombin-stimulated platelets.{27715,27713} R-59-022 also blocks vascular contraction induced by the thromboxane analog U-46619 (Item No. 16450).{27712} At 10 µM, R-59-022 induces apoptosis in glioblastoma cells without being toxic to non-cancerous cells.{27710} It inhibits DGK-? in vitro at concentrations below 1 µM and blocks DGK-? activity in vivo.{27714} R-59-022 also inhibits A. thaliana DGK2 (IC50 = 50 µM) and suppresses root growth but does not affect DGK7 at 50 µM.{27711}
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.